If you don't see your question here, our team is a message away.
FLA Peptides operates in partnership with a licensed medical practice and licensed pharmacy partners. Research peptides are not FDA-approved, and compounded medications are not FDA-approved products — they're prepared for you individually under a valid prescription after clinical review. We're upfront about that status for every item, and nothing is dispensed without a provider reviewing your labs first.
No. Anyone can request portal access and go through the standard intake and lab review. If you're an existing clinic patient who has since moved, let us know — we can set up your account directly so you can keep your protocol without starting over.
It depends on the protocol. Most require some combination of a Comprehensive Metabolic Panel (CMP), Complete Blood Count (CBC), lipid panel, or IGF-1. These give your provider a baseline picture of organ function, blood counts, and (for growth-hormone-related protocols) hormone response, so dosing decisions are based on your actual physiology rather than a guess.
We offer labs at cost through our Fullscript partner network — you'll see the exact price for your specific panel before you order, and it depends on which labs your protocol requires. If you have insurance, let us know — we can often order your labs under your coverage instead. Every protocol needs at least a current CMP. If you've had labs done within the last 12 months through your own provider, just email them over and our medical team will confirm whether they cover what's needed.
Often, yes. If you have insurance, let us know when you request access and we can order your labs under your coverage instead of the at-cost Fullscript price. Coverage depends on your specific plan and which labs your protocol requires, so our team will confirm what applies to you before anything is ordered. Peptide and compounded-medication protocols themselves are typically self-pay, but the labs behind them are often billable to insurance.
Your request is placed on hold rather than automatically denied. A provider will reach out to explain what was out of range and what your options are — that might mean addressing the underlying issue first, adjusting the protocol, or in some cases determining the protocol isn't a fit right now.
Most protocols are set to a 90-day retest cadence. Some, particularly growth-hormone-related protocols monitored via IGF-1, may be checked sooner. You'll get a reminder in your portal when a retest is coming up.
Most of the research peptides in our library (BPC-157, TB-500, CJC-1295, Ipamorelin) are not FDA-approved for the uses discussed here. PT-141 has an FDA-approved form for a specific indication; other formulations are prescribed at a provider's discretion. Compounded medications, including personalized GLP-1 formulations, are not themselves FDA-approved products, and their availability depends on current pharmacy regulations, which we monitor closely.
We don't sell without a reviewed lab panel and a licensed provider's sign-off, and we schedule retesting rather than leaving it up to you to remember. Compounded medications also require a telehealth visit. If a protocol isn't appropriate for you based on your labs or history, we'll tell you — even if that means not fulfilling a request.
Reach out through the contact page and let us know what you're looking for. If it's something our medical team supports, we'll route you to the right intake and lab requirements.
In many cases, yes — let us know and we'll set up your portal account directly. Availability can depend on state-specific telehealth and pharmacy rules, so our team will confirm what's possible for your new location before anything is approved.
